Pro Doc Irbesartan Product Recall (2019-03-11)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
| Lot or serial number | Companies | Brand name | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| 601795 | - Recalling Firm
- Pro Doc Ltd.
- 2925 Industrial Blvd.
- Laval
- H7L 3W9
- Quebec
- CANADA
- Marketing Authorization Holder
- Pro Doc Ltd.
- 2925 Industrial Blvd.
- Laval
- H7L 3W9
- Quebec
- CANADA
| B. Irbesartan 300mg Tablet | Tablet | DIN 02365219 | Irbesartan 300mg |
| 604292 | - Recalling Firm
- Pro Doc Ltd.
- 2925 Industrial Blvd.
- Laval
- H7L 3W9
- Quebec
- CANADA
- Marketing Authorization Holder
- Pro Doc Ltd.
- 2925 Industrial Blvd.
- Laval
- H7L 3W9
- Quebec
- CANADA
| A. Irbesartan 150mg Tablet | Tablet | DIN 02365200 | Irbesartan 150mg |
Recalled Products
-
Irbesartan 150mg Tablet
-
Irbesartan 300mg Tablet
Affected lots manufactured with an API that contains the impurity N-nitrosodiéthylamine (otherwise known as “ndea”) above the acceptable level.